loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 204326 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Neos Therapeutics

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 NEOS THERAPS (6)

    filter

    01 TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL (6)

    filter

    01 RX (6)

    filter

    01 ADZENYS XR-ODT (6)

    filter

    01 Yes (6)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    AMPHETAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, ORALLY DIS...
    EQ 15.7MG BASE
    2016-01-27
    204326
    ADZENYS XR-ODT
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    AMPHETAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, ORALLY DIS...
    EQ 9.4MG BASE
    2016-01-27
    204326
    ADZENYS XR-ODT
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    AMPHETAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, ORALLY DIS...
    EQ 3.1MG BASE
    2016-01-27
    204326
    ADZENYS XR-ODT
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    AMPHETAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, ORALLY DIS...
    EQ 18.8MG BASE
    2016-01-27
    204326
    ADZENYS XR-ODT
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    AMPHETAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, ORALLY DIS...
    EQ 12.5MG BASE
    2016-01-27
    204326
    ADZENYS XR-ODT
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    AMPHETAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, ORALLY DIS...
    EQ 6.3MG BASE
    2016-01-27
    204326
    ADZENYS XR-ODT
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 204326

    Looking for FDA Orange Book APPLICATION 204326 6

    19

    Neos Therapeutics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is AMPHETAMINE, with a corresponding application number 204326.

    Regulatory Information RX

    With a dosage strength EQ 15.7MG BASE

    Dosage Form Route TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2016-01-27

    18

    Neos Therapeutics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is AMPHETAMINE, with a corresponding application number 204326.

    Regulatory Information RX

    With a dosage strength EQ 9.4MG BASE

    Dosage Form Route TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2016-01-27

    17

    Neos Therapeutics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is AMPHETAMINE, with a corresponding application number 204326.

    Regulatory Information RX

    With a dosage strength EQ 3.1MG BASE

    Dosage Form Route TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2016-01-27

    16

    Neos Therapeutics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is AMPHETAMINE, with a corresponding application number 204326.

    Regulatory Information RX

    With a dosage strength EQ 18.8MG BASE

    Dosage Form Route TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2016-01-27

    15

    Neos Therapeutics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is AMPHETAMINE, with a corresponding application number 204326.

    Regulatory Information RX

    With a dosage strength EQ 12.5MG BASE

    Dosage Form Route TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2016-01-27

    14

    Neos Therapeutics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is AMPHETAMINE, with a corresponding application number 204326.

    Regulatory Information RX

    With a dosage strength EQ 6.3MG BASE

    Dosage Form Route TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2016-01-27

    Post Enquiry
    POST ENQUIRY